Evidence map›Paper›PMID 20969591›Full record

ReviewImmunological reviews2010

Multilayered specification of the T-cell lineage fate.

Ellen V Rothenberg, Jingli Zhang, Long Li

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 80 citations in OpenAlex.

  1. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  2. A regulatory network of microRNAs confers lineage commitment during early developmental trajectories of B and T lymphocytes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ellen V RothenbergDivision of Biology, California Institute of Technology, Pasadena, CA 91125, USA. evroth@its.caltech.edu
Jingli Zhang
Long Li
California Institute of Technology · US

Funding

LINEAGE COMMITMENT MECHANISMS IN LYMPHOID PRECURSORSR01CA090233 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2001 to 2011
$3.9M
Reverse engineering genetic network architecture of stem-cell/lymphocyte transitiR33HL089123 · NHLBI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2007 to 2009
$1.6M
Dynamic Epigenetic Mapping of a Stem Cell Differentiation ChoiceRC2CA148278 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V., WOLD, BARBARA J · 2009 to 2010
$1.6M
NCI NIH HHS R01 CA090233NCI NIH HHS R01 CA90233NCI NIH HHS RC2 CA148278NHLBI NIH HHS R33 HL089123
6 · The paper itself

Abstract

T-cell development from stem cells has provided a highly accessible and detailed view of the regulatory processes that can go into the choice of a cell fate in a postembryonic, stem cell-based system. But it has been a view from the outside. The problems in understanding the regulatory basis for this lineage choice begin with the fact that too many transcription factors are needed to provide crucial input: without any one of them, T-cell development fails. Furthermore, almost all the factors known to provide crucial functions during the climax of T-lineage commitment itself are also vital for earlier functions that establish the pool of multilineage precursors that would normally feed into the T-cell specification process. When the regulatory genes that encode them are mutated, the confounding effects on earlier stages make it difficult to dissect T-cell specification genetically. Yet both the positive and the negative regulatory events involved in the choice of a T-cell fate are actually a mosaic of distinct functions. New evidence has emerged recently that finally provides a way to separate the major components that fit together to drive this process. Here, we review insights into T-cell specification and commitment that emerge from a combination of molecular, cellular, and systems biology approaches. The results reveal the regulatory structure underlying this lineage decision.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCell DifferentiationCell LineageGene Regulatory NetworksHematopoietic Stem CellsHumansRepressor ProteinsT-LymphocytesT-Lymphocyte SubsetsTumor Suppressor ProteinsBCL11B protein, humanRepressor ProteinsTumor Suppressor Proteins

Identifiers

PMID20969591
PMCPMC2965335
OpenAlexW1525824369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.